Your browser doesn't support javascript.
loading
Inhibition of SIRT6 in prostate cancer reduces cell viability and increases sensitivity to chemotherapeutics.
Liu, Yewei; Xie, Qian Reuben; Wang, Boshi; Shao, Jiaxiang; Zhang, Tingting; Liu, Tengyuan; Huang, Gang; Xia, Weiliang.
Afiliación
  • Liu Y; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, 200030, China.
  • Xie QR; Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
  • Wang B; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, 200030, China.
  • Shao J; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, 200030, China.
  • Zhang T; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, 200030, China.
  • Liu T; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, 200030, China.
  • Huang G; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, 200030, China.
  • Xia W; Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China. huang2802@163.com.
Protein Cell ; 4(9): 702-10, 2013 Sep.
Article en En | MEDLINE | ID: mdl-23982738

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Sirtuinas Tipo de estudio: Diagnostic_studies Límite: Humans / Male Idioma: En Revista: Protein Cell Asunto de la revista: BIOQUIMICA Año: 2013 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Sirtuinas Tipo de estudio: Diagnostic_studies Límite: Humans / Male Idioma: En Revista: Protein Cell Asunto de la revista: BIOQUIMICA Año: 2013 Tipo del documento: Article País de afiliación: China